Stock OSL ONCOSIL MEDICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News OncoSil Medical Limited

Equities

OSL

AU000000OSL3

Market Closed - Australian S.E.
Other stock markets
 02:10:53 2024-05-16 EDT 		5-day change 1st Jan Change
0.005 AUD 0.00% Intraday chart for OncoSil Medical Limited +11.11% -44.44%
05-02 OncoSil Medical Raises AU$5.3 Million under Entitlement Offer MT
04-18 OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OncoSil Medical Raises AU$5.3 Million under Entitlement Offer
MT
OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial
MT
OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device
MT
OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study
MT
OncoSil Medical Obtains Device Reimbursement Approval in UK
MT
First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device
MT
Rights Issue: 1 new share @ 0.005 AUD for 2 existing shares
FA
Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus
MT
Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer
MT
OncoSil Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade
MT
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%
MT
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%
MT
OncoSil Medical Receives AU$1.1 Million R&D Tax Rebate
MT
First Patient Treated in OncoSil Medical's Pancreatic Cancer Drug Trial
MT
Oncosil Medical Limited Elects Gabrielle Liberatore as Director
CI
Australian Shares Rise on Expectations of Easing October CPI
MT
OncoSil Medical Secures Insurer Clearance for Pancreatic Cancer Device in Israel
MT
OncoSil Medical Limited Announces Retirement of Brian Leedman from the Board
CI
OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OSL Stock
  4. News OncoSil Medical Limited
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**